Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No Help from Dalfampridine in MS-Related Optic Neuritis
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
[Emerging therapies for multiple sclerosis.]
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
[Anti-NMDA receptor encephalitis - case report].
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
B cell exchange across the blood-brain barrier in multiple sclerosis.
Early detection of MS treatment complication may improve survival
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Oral laquinimod for multiple sclerosis.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.

Pages